Recombinant human TL1A/TNFSF15 protein

Cat No.
ATGP4084

Size

QTY

List Price

10ug

USD 130


20ug

USD 240

50ug

USD 320

100ug

USD 530

250ug

USD 930

500ug

USD 1,590

1mg

USD 2,650

USD 0



Product Information

Product Type
Recombinant Protein
Expression System
E.coli
Domain
72-251aa
UniProt No.
O95150
NCBI Accession No.
NP_005109.2
Alternative names
TNF superfamily member 15, TNF ligand-related molecule 1, TL1, Vascular endothelial cell growth inhibitor, VEGI, TNF superfamily ligand TL1A, TL1A, Vascular endothelial growth inhibitor-192A, VEGI192A

Product Specification

Molecular Weight
22.7 kDa (201aa) confirmed by MALDI-TOF
Concentration
0.5mg/ml (determined by Bradford assay)
Formulation
Liquid in. 20mM Tris-HCl buffer (pH 8.5) containing 0.15M NaCl, 40% glycerol
Purity
> 90% by SDS-PAGE
Bioactivity
Measured by its ability to induce apoptosis in TF-1 human erythroleukemic cells in the presence of cycloheximaide. The ED50 range ≤ 100ng/ml.
Endotoxin
< 1 EU per 1ug of protein (determined by LAL method)
Tag
His-Tag
Applications
SDS-PAGE, Bioactivity
Storage
Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Data

SDS-PAGE

3ug by SDS-PAGE under reducing condition and visualized by coomassie blue stain

Biological Activity

Human TNFSF15 induces apoptosis in TF-1 human erythroleukemic cells in the presence of cycloheximaide. The ED50 range ≤ 100 ng/ml.

Note: For research use only. This product is not intended or approved for human, diagnostics or veterinary use.